Risks of intestinal anastomoses in Crohn's disease
- PMID: 1985536
- PMCID: PMC1358308
- DOI: 10.1097/00000658-199101000-00007
Risks of intestinal anastomoses in Crohn's disease
Abstract
Six hundred fifty-eight intestinal anastomoses in 429 operations for Crohn's disease were studied prospectively during an 8-year period to detect variables connected with perioperative morbidity. Postoperative complications occurred in 9.7% of the patients, 4% had to be reoperated on, and the overall mortality rate was 0.5%. In multivariate analysis by stepwise logistic regression, the only variable significantly (p = 0.03) associated with overall rate of complications was long-term corticosteroid therapy. Serious complications were more common in cases of intra-abdominal abscesses (p = 0.01) and preoperative steroid medication (p = 0.03). The combination of both of these risk factors increased the rate of reoperations from 0.6% (no steroids, no abscess) to 16% (steroids and abscess). No significant association with postoperative complications could be found for age, sex, duration of disease, previous operations, nutritional status, emergency surgery, extent of disease, type, number, and localization of anastomoses, presence of proximal ileo-/colostomy, or histologically inflamed margins of resection.
Similar articles
-
Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn's disease.Dis Colon Rectum. 2012 Sep;55(9):957-62. doi: 10.1097/DCR.0b013e3182617716. Dis Colon Rectum. 2012. PMID: 22874602
-
Risk factors for intra-abdominal sepsis after surgery in Crohn's disease.Dis Colon Rectum. 2000 Aug;43(8):1141-5. doi: 10.1007/BF02236563. Dis Colon Rectum. 2000. PMID: 10950014
-
Positive histological inflammatory margins are associated with increased risk for intra-abdominal septic complications in patients undergoing ileocolic resection for Crohn's disease.Dis Colon Rectum. 2012 Nov;55(11):1125-30. doi: 10.1097/DCR.0b013e318267c74c. Dis Colon Rectum. 2012. PMID: 23044672
-
Patient optimization for surgery relating to Crohn's disease.Nat Rev Gastroenterol Hepatol. 2016 Dec;13(12):707-719. doi: 10.1038/nrgastro.2016.158. Epub 2016 Oct 26. Nat Rev Gastroenterol Hepatol. 2016. PMID: 27780971 Review.
-
Risk factors for postoperative intra-abdominal septic complications after surgery in Crohn's disease: A meta-analysis of observational studies.J Crohns Colitis. 2015 Mar;9(3):293-301. doi: 10.1093/ecco-jcc/jju028. Epub 2015 Jan 8. J Crohns Colitis. 2015. PMID: 25572276 Review.
Cited by
-
Effect of immunosuppressive medication on postoperative complications following abdominal surgery in Crohn's disease patients.Int J Colorectal Dis. 2022 Dec;37(12):2535-2542. doi: 10.1007/s00384-022-04287-4. Epub 2022 Nov 28. Int J Colorectal Dis. 2022. PMID: 36441196 Free PMC article.
-
Long-term efficacy of strictureplasty for Crohn's disease.Surg Today. 2010 Oct;40(10):949-53. doi: 10.1007/s00595-009-4162-y. Epub 2010 Sep 25. Surg Today. 2010. PMID: 20872198
-
Effect of perioperative immunosuppressive medication on early outcome in Crohn's disease patients.World J Surg. 2009 May;33(5):1049-52. doi: 10.1007/s00268-009-9957-x. World J Surg. 2009. PMID: 19277774
-
Risk factors and implications of anastomotic complications after surgery for Crohn's disease.World J Gastrointest Surg. 2015 Oct 27;7(10):237-42. doi: 10.4240/wjgs.v7.i10.237. World J Gastrointest Surg. 2015. PMID: 26523211 Free PMC article. Review.
-
Treatment of the anastomotic complications in patients with Crohn's disease.Int J Colorectal Dis. 2011 Feb;26(2):239-44. doi: 10.1007/s00384-010-1031-5. Epub 2010 Aug 6. Int J Colorectal Dis. 2011. PMID: 20689958 Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical